Apable, Joaressa Fe S.
HRN: 22-25-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/05/2022
12/11/2022
IVT
600mg Ivt
Q6 X 7 Days
Fracture Prophylaxis, Skin Abrasions
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes